Cargando…

Association of coronary microvascular dysfunction and cardiac bridge integrator 1, a cardiomyocyte dysfunction biomarker

BACKGROUND: Coronary microvascular dysfunction (CMD) is associated with heart failure with preserved ejection fraction (HFpEF); however, pathophysiology is not well described. HYPOTHESIS: We hypothesized that CMD in women with suspected ischemia with no obstructive coronary artery disease (INOCA) is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pacheco, Christine, Wei, Janet, Shufelt, Chrisandra, C. Hitzeman, Tara, Cook‐Wiens, Galen, Pepine, Carl J., Handberg, Eileen, Anderson, R. David, Petersen, John, Hong, TingTing, M. Shaw, Robin, Bairey Merz, C. Noel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Periodicals, Inc. 2021
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571552/ https://www.ncbi.nlm.nih.gov/pubmed/34528718 http://dx.doi.org/10.1002/clc.23726

Ejemplares similares

Coronary endothelial dysfunction appears to be a manifestation of a systemic process: A report from the Women’s Ischemia Syndrome Evaluation – Coronary Vascular Dysfunction (WISE-CVD) study
por: Jalnapurkar, Sawan, et al.
Publicado: (2021)

N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women’s Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD) study
por: Jones, Erika, et al.
Publicado: (2020)

Relationship between coronary function testing and migraine: results from the Women’s Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction project
por: Siak, Jessica, et al.
Publicado: (2021)

Autoimmune rheumatic diseases in women with coronary microvascular dysfunction: a report from the Women's Ischemia Syndrome Evaluation—Coronary Vascular Dysfunction (WISE-CVD) project
por: Chen, Melanie T., et al.
Publicado: (2023)

Daily Activity Measured With Wearable Technology as a Novel Measurement of Treatment Effect in Patients With Coronary Microvascular Dysfunction: Substudy of a Randomized Controlled Crossover Trial
por: Birkeland, Kade, et al.
Publicado: (2017)

Typical angina is associated with greater coronary endothelial dysfunction but not abnormal vasodilatory reserve
por: AlBadri, Ahmed, et al.
Publicado: (2017)

Predicted Versus Observed Major Adverse Cardiac Event Risk in Women With Evidence of Ischemia and No Obstructive Coronary Artery Disease: A Report From WISE (Women's Ischemia Syndrome Evaluation)
por: Sedlak, Tara, et al.
Publicado: (2020)

A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve
por: Bairey Merz, C. Noel, et al.
Publicado: (2016)

Trans-myocardial omega-3 fatty acid gradient in coronary microvascular dysfunction
por: Keeley, Ellen C., et al.
Publicado: (2022)

Cardiovascular and pregnancy outcomes in women with coronary microvascular dysfunction: a case series
por: Pacheco, Christine, et al.
Publicado: (2019)

Renal Function and Coronary Microvascular Dysfunction in Women with Symptoms/Signs of Ischemia
por: Mohandas, Rajesh, et al.
Publicado: (2015)

Left ventricular mass and myocardial scarring in women with hypertensive disorders of pregnancy
por: Quesada, Odayme, et al.
Publicado: (2020)

Progression of coronary microvascular dysfunction to heart failure with preserved ejection fraction: a case report
por: Joung, Sandy, et al.
Publicado: (2019)

Comparison of fully quantitative and semi-quantitative measure of women's myocardial perfusion reserve for detection of microvascular coronary dysfunction
por: Chen, David, et al.
Publicado: (2013)

THE IMPACT OF THE COVID-19 PANDEMIC ON A MULTI-CENTER CLINICAL - ADAPTING IN REAL-TIME TO MAINTAIN TRIAL INTEGRITY
por: Dasa, Osama, et al.
Publicado: (2021)

Temporal Trends in Angina, Myocardial Perfusion, and Left Ventricular Remodeling in Women With No Obstructive Coronary Artery Disease Over 1‐Year Follow‐Up: Results From WISE‐CVD
por: Quesada, Odayme, et al.
Publicado: (2020)

Age at Menarche and Risk of Cardiovascular Disease Outcomes: Findings From the National Heart Lung and Blood Institute‐Sponsored Women's Ischemia Syndrome Evaluation
por: Lee, Julie J., et al.
Publicado: (2019)

OR19-6 Functional Hypothalamic Amenorrhea and Preclinical Cardiovascular Disease
por: Bairey Merz, C Noel, et al.
Publicado: (2022)

SAT-LB99 Inflammation May Mediate Coronary Artery Disease in Women With Hypothalamic Hypoestrogenemia: Findings From the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE)
por: Torbati, Tina, et al.
Publicado: (2020)

Do women with statin-related myalgias have low vitamin D levels?
por: Minissian, Margo, et al.
Publicado: (2015)

Coronary Microvascular Dysfunction: What Clinicians and Investigators Should Know
por: Marano, Paul, et al.
Publicado: (2023)

Prevalence of Coronary Endothelial and Microvascular Dysfunction in Women with Symptoms of Ischemia and No Obstructive Coronary Artery Disease Is Confirmed by a New Cohort: The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD)
por: Anderson, R. David, et al.
Publicado: (2019)

Ultra-high sensitivity cardiac troponin-I concentration and left ventricular structure and function in women with ischemia and no obstructive coronary artery disease
por: Quesada, Odayme, et al.
Publicado: (2022)

Ischemia and No Obstructive Coronary Artery Disease (INOCA): What Is the Risk?
por: Herscovici, Romana, et al.
Publicado: (2018)

Fitness attenuates long-term cardiovascular outcomes in women with ischemic heart disease and metabolic syndrome
por: Quesada, Odayme, et al.
Publicado: (2023)

Gender-Related Differences in Chest Pain Syndromes in the Frontiers in CV Medicine Special Issue: Sex & Gender in CV Medicine
por: Mehta, Puja K., et al.
Publicado: (2021)

Acetylcholine versus cold pressor testing for evaluation of coronary endothelial function
por: AlBadri, Ahmed, et al.
Publicado: (2017)

Sex differences in contributors to coronary microvascular dysfunction
por: Kwan, Alan C., et al.
Publicado: (2023)

Cold Pressor Stress Cardiac Magnetic Resonance Myocardial Flow Reserve Is Not Useful for Detection of Coronary Endothelial Dysfunction in Women with Signs and Symptoms of Ischemia and No Obstructive CAD
por: Landes, Sofy, et al.
Publicado: (2017)

Internal medicine resident education improves cardiac rehabilitation knowledge, attitudes, and referral rates: A pilot study
por: Wang, Maggie, et al.
Publicado: (2022)

Interscan reproducibility of cardiovascular magnetic resonance myocardial perfusion reserve index in women with suspected coronary microvascular dysfunction and no obstructive coronary artery disease
por: AlBadri, Ahmed, et al.
Publicado: (2016)

Angina Hospitalization Rates in Women With Signs and Symptoms of Ischemia But no Obstructive Coronary Artery Disease: A Report from the WISE (Women's Ischemia Syndrome Evaluation) Study
por: Aldiwani, Haider, et al.
Publicado: (2020)

Native myocardial T1 is elevated in subjects with coronary microvascular dysfunction and no obstructive CAD
por: Shaw, Jaime L, et al.
Publicado: (2015)

Subclinical systolic and diastolic dysfunction in women with signs and symptoms of ischemia but no obstructive coronary disease: novel insights using myocardial feature tracking in the NHLBI WISE study
por: Nelson, Michael D, et al.
Publicado: (2016)

Inter-scan Reproducibility of Cardiovascular Magnetic Resonance Imaging-Derived Myocardial Perfusion Reserve Index in Women with no Obstructive Coronary Artery Disease
por: Al-Badri, Ahmed, et al.
Publicado: (2018)

Projection imaging of myocardial perfusion: minimizing the subendocardial dark-rim artifact
por: Sharif, Behzad, et al.
Publicado: (2012)

Coronary Microvascular Dysfunction in Patients With Systemic Lupus Erythematosus and Chest Pain
por: Manchanda, Ashley S., et al.
Publicado: (2022)

Clinical Practice Variations in the Management of Ischemia With No Obstructive Coronary Artery Disease
por: Luu, Judy M., et al.
Publicado: (2022)

Five-year stroke rate in women with signs and symptoms of ischemia undergoing coronary angiography: a retrospective study from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE)
por: Haftbaradaran, A, et al.
Publicado: (2015)

Circulating Biomarkers in Coronary Microvascular Dysfunction
por: Chakrala, Teja, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_se4kj8k829kbn5n4cl6rukjk4j